Skip to main content
Log in

Management of Dabigatran-associated bleeding in two elderly patients with acute renal failure

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdf (accessed December 17, 2017)

  2. http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Praxbind/Praxbind.pdf (accessed December 17, 2017)

  3. http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf (accessed December 17, 2017)

  4. Simon A, Domanovits H, Ay C, Sengoelge G, Levy JH, Spiel AO (2017) The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran. J Thromb Haemost 15:1317–1321

    Article  CAS  Google Scholar 

  5. Yip L, Deng FJ (2018) Idarucizumab dosing in kidney failure. Am J Kidney Dis 71:146

    Article  Google Scholar 

  6. Stecher A, Vene N, Mavri A, Mijovski MB, Krevel B, Gradisek P (2017) Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure. Eur J Anesthesiol 34:400–402

    Article  Google Scholar 

  7. Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M (2015) Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. J Thromb Haemost 13:1790–1798

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sirak Petros.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pfrepper, C., Peschka, A., Weidhase, L. et al. Management of Dabigatran-associated bleeding in two elderly patients with acute renal failure. Ann Hematol 97, 2519–2521 (2018). https://doi.org/10.1007/s00277-018-3376-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-018-3376-8

Navigation